What is the price target for Tesla after the upgrade?
UBS set a price target of $352 for Tesla.
Finance / Market Analysis
Stay informed about the latest Wall Street analyst moves. This article summarizes key upgrades, downgrades, and initiations, focusing on Tesla (TSLA) and AppLovin (APP), providing insights into potential market shifts and investment opportu...
This week's analyst calls reveal several key shifts in Wall Street's outlook on major companies. Tesla's upgrade suggests a recalibration of expectations, balancing current demand concerns with future AI prospects. AppLovin's initiation with a Buy rating underscores its resilience and growth potential in the face of market headwinds. The upgrades for General Motors and Crocs further highlight specific opportunities within the automotive and consumer sectors, respectively. Fastly's initiation with an Outperform rating signals potential for growth in the AI infrastructure space.
**How to Prepare:**
**Who This Affects Most:**
UBS set a price target of $352 for Tesla.
Argus cited AppLovin's strong double-digit revenue growth and profit margin expansion.
Deutsche Bank upgraded GM due to recent share pullback, seeing it as an attractive entry point.
Do you think these analyst upgrades and initiations will impact stock performance? Share your thoughts in the comments below!
Share this article with others who need to stay ahead of this trend!
This article was compiled by Yanuki using publicly available data and trending information. The content may summarize or reference third-party sources that have not been independently verified. While we aim to provide timely and accurate insights, the information presented may be incomplete or outdated.
All content is provided for general informational purposes only and does not constitute financial, legal, or professional advice. Yanuki makes no representations or warranties regarding the reliability or completeness of the information.
This article may include links to external sources for further context. These links are provided for convenience only and do not imply endorsement.
Always do your own research (DYOR) before making any decisions based on the information presented.